Financial Performance - Net Revenue for Q1 2025 was $2,878 million, a 25.9% increase from $2,286 million in Q1 2024[3] - Gross Profit for Q1 2025 reached $338 million, up 15.7% compared to $292 million in Q1 2024[3] - Net Income from Continuing Operations was $9.2 million, a significant improvement from a Net Loss of $56.0 million in Q1 2024[3] - Adjusted EBITDA for Q1 2025 was $131 million, reflecting a 28.2% increase from $102 million in Q1 2024[4] - Total Segment Adjusted EBITDA for Q1 2025 was $167 million, a 24% increase from $135 million in Q1 2024[6] - Total revenues for Q1 2025 reached $2,878,129, a 26% increase from $2,285,766 in Q1 2024[28] - Gross profit for Q1 2025 was $338,369, compared to $292,491 in Q1 2024, reflecting a 15.7% increase[28] - Net income attributable to BrightSpring Health Services, Inc. was $29,542 for Q1 2025, a significant recovery from a net loss of $45,750 in Q1 2024[28] - Adjusted EBITDA for Q1 2025 was $131,062, up from $102,215 in Q1 2024, indicating a 28.3% growth[32] Revenue Breakdown - Pharmacy Solutions Revenue for Q1 2025 was $2,532 million, a 28% increase from $1,977 million in Q1 2024[6] - Provider Services Revenue for Q1 2025 was $346 million, up 12% from $309 million in Q1 2024[6] Guidance and Projections - Full Year 2025 Revenue guidance increased to $12,000 - $12,500 million, representing a growth of 19.1% to 24.1%[9] - Adjusted EBITDA guidance for 2025 is set at $570 - $585 million, indicating a growth of 23.9% to 27.2%[9] Cash Flow and Assets - The company reported a net cash provided by operating activities of $101,598 for Q1 2025, a turnaround from a net cash used of $78,859 in Q1 2024[30] - Cash and cash equivalents decreased to $52,337 as of March 31, 2025, down from $60,954 at the end of 2024[26] - Total current assets increased to $2,528,448 as of March 31, 2025, compared to $1,893,054 at the end of 2024, marking a 33.6% rise[26] - Total assets decreased to $5,846,945 as of March 31, 2025, from $5,926,140 at the end of 2024, a decline of 1.3%[26] - Long-term debt, net of current portion, decreased to $2,489,339 as of March 31, 2025, from $2,561,858 at the end of 2024, a reduction of 2.8%[26] Earnings Per Share - Basic income per share from continuing operations was $0.05 for Q1 2025, compared to a loss of $0.31 in Q1 2024[28] - For Q1 2025, diluted EPS from continuing operations was $0.05, compared to $(0.31) in Q1 2024[34] - Adjusted EPS for Q1 2025 was $0.19, an increase from $0.09 in Q1 2024[34] - The weighted average common shares outstanding used in calculating diluted EPS increased to 214,927 thousand in Q1 2025 from 175,531 thousand in Q1 2024[34] Cost Contributions - Non-cash share-based compensation contributed $0.06 to adjusted EPS in Q1 2025, down from $0.13 in Q1 2024[34] - Acquisition, integration, and transaction-related costs contributed $0.04 to adjusted EPS in Q1 2025, compared to $0.05 in Q1 2024[34] - Restructuring and divestiture-related costs contributed $0.08 to adjusted EPS in Q1 2025, down from $0.13 in Q1 2024[34] - The income tax impact on adjustments was $(0.04) for Q1 2025, compared to $(0.11) in Q1 2024[34] Divestiture Plans - The planned divestiture of the Community Living business to Sevita is on track to be completed this year[5]
Brightspring Health Services, Inc.(BTSGU) - 2025 Q1 - Quarterly Results